Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Fortress Biotech, Inc. (FBIO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Fortress Biotech, Inc. (FBIO), most recent 12 months reported: revenue $68.47M, net income $111.82M. Latest balance sheet on file: liquid cash $196.58M, total debt $39.6M, net cash $156.97M. From SEC filings. Others in Pharmaceutical Preparations: KURA ONCOLOGY, INC. · Assembly Biosciences, Inc. · Viridian Therapeutics, Inc./DE · ROCKWELL MEDICAL, INC. · Journey Medical Corp · CYTOKINETICS, INCORPORATED · AbCellera Biologics Inc. · WAVE LIFE SCIENCES, INC.

Stock screener

Watchlist